Xconomy’s Digital Events →
Investor sentiment still backing growth for pharma and biotech sectors, but the length and severity of COVID-19’s impact globally has yet to be seen.
Confirmation that the coronavirus has reached pandemic... Read more »
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
Xconomy Insight · Special Report
Industry experts explain what it takes to launch a new biotech company
The AI, Big Data, and R&D Boom
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.